Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 11Breast 9Thoracic 6Head & Neck 5Genitourinary 5Other hematologic neoplasm 4Sarcoma 3Lymphoid 3Dermatologic 3Tumor-Agnostic 2Other solid neoplasm 2Gynecologic 2Gastrointestinal 2Myeloid 1

Conditions

Melanoma 3Lymphatic Metastasis 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 195aldesleukin 148Interleukin-2 110fludarabine phosphate 107trametinib 85Temozolomide 83fludarabine 81Dacarbazine 81dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Magnetic Resonance Spectroscopy 50Specimen Handling 49Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Aminolevulinic Acid 49binimetinib 48Carboplatin 48Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
alovudine × Dermatologic × Clear all
NCT04221438 2026-05-29

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Eastern Cooperative Oncology Group

Phase 2 Terminated
3 enrolled 11 charts
Dermatologic

Lymphatic Metastasis, Melanoma

NCT03356470 2026-01-28

Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma

University of Wisconsin, Madison

Completed
5 enrolled
Dermatologic

Melanoma

NCT02891616 2019-07-17

18F-FLT PET Imaging in Patients With Advanced Melanoma

Washington University School of Medicine

Phase 1 Terminated
4 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡